• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Main Content

  • BD issues voluntary recall on certain Alaris infusion pump modules

    BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall

    Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J

    Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

    Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation

    Medtronic Diabetes names CFO with consumer experience ahead of separation

Drug Tech

Medtronic Onyx LES (1)

Medtronic enrolls first patient in study for Onyx liquid embolic system

Medtronic [WtwhTicker symbol="MDT"](NYSE: MDT)[/WtwhTicker] today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES). PELE (Peripheral Onyx Liquid Embolic) evaluates the safety of Onyx LES for the … [Read More...] about Medtronic enrolls first patient in study for Onyx liquid embolic system

Today on Drug Delivery Business

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany

Sponsored Content

Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI

September 6, 2023 By Sponsored Content

Manufacturing automation is crucial to achieving the precision, quality, and volume required in the medical device industry. Advanced robotics, AI, modular designs, and wireless technology offer the … [Read More...] about Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI

More Sponsored Content >>

Featured Posts

BD Alaris Infusion System updated FDA clearance

BD issues voluntary recall on certain Alaris infusion pump modules

July 16, 2025 By Sean Whooley

BD (NYSE:BDX) announced a voluntary recall related to certain Alaris and Alaris infusion pump modules. Affected Alaris products may have been serviced with previously recalled bezel kit assemblies. BD in 2019 recalled those kit assemblies … [Read More...] about BD issues voluntary recall on certain Alaris infusion pump modules

Abbott FreeStyle Libre 3 Plus Sequel Med Tech Twiist

Sequel Med Tech expects full twiist launch in the fall

July 15, 2025 By Sean Whooley

Sequel Med Tech has offered insight into the next steps of the launch of its twiist automated insulin delivery (AID) system. The company shared at last month's American Diabetes Association’s 85th Scientific Sessions in Chicago that it planned to … [Read More...] about Sequel Med Tech expects full twiist launch in the fall

Lisa Blair Davis LinkedIn Insulet

Insulet hires new chief HR officer from J&J

July 10, 2025 By Sean Whooley

Insulet (Nasdaq:PODD) announced that it named Lisa Blair Davis as its new SVP and chief human resources officer. She joins the automated insulin delivery technology maker from Johnson & Johnson. There, she most recently served as VP of global … [Read More...] about Insulet hires new chief HR officer from J&J

Breakthrough T1D Mattel Barbie T1D (1)

Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

July 9, 2025 By Sean Whooley

Breakthrough T1D (formerly JDRF) and Mattel announced a partnership to debut the first Barbie doll with type 1 diabetes (T1D). They say the global collaboration reflects a shared commitment to ensure that people with T1D are "seen, heard and … [Read More...] about Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

Chad Spooner Medtronic MiniMed CFO

Medtronic Diabetes names CFO with consumer experience ahead of separation

July 8, 2025 By Sean Whooley

Medtronic (NYSE:MDT) announced today that it appointed Chad Spooner as CFO of MiniMed in advance of its intended separation. Effective July 14, Spooner takes responsibility for overseeing the finance function for Medtronic Diabetes/MiniMed. His … [Read More...] about Medtronic Diabetes names CFO with consumer experience ahead of separation

Diabeloop Sooil DBLG1 Dana-i pump Dexcom G6

Diabeloop launches insulin delivery algorithm in Germany

July 8, 2025 By Sean Whooley

Diabeloop today announced the commercial availability of its DBLG1 algorithm with the Dana-i insulin pump from Sooil in Germany. The companies distribute their automated insulin delivery offering through Mediq, a leading European diabetes … [Read More...] about Diabeloop launches insulin delivery algorithm in Germany

GlucoModicum needle-free CGM (1)

GlucoModicum has positive data for needle-free CGM

July 2, 2025 By Sean Whooley

GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose monitor (CGM). Helsinki, Finland-based GlucoModicum said in a news release that the study helps put the company on "a clear path … [Read More...] about GlucoModicum has positive data for needle-free CGM

Screenshot of the Lifecare implantable CGM technology

Lifecare takes next steps in CGM implant development

July 2, 2025 By Sean Whooley

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor (CGM) implant. The Norway-based company says it completed the initial electromagnetic compatibility (EMC) testing of … [Read More...] about Lifecare takes next steps in CGM implant development

ADA Logo in Chicago American Diabetes Association 85th Scientific Sessions

The biggest diabetes tech stories out of ADA 2025

June 24, 2025 By Sean Whooley

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th Scientific Sessions. At last year's edition in Orlando, type 2 diabetes dominated the conversation. This time around, type 2 … [Read More...] about The biggest diabetes tech stories out of ADA 2025

Senseonics Ascensia Eversense 365 product image separate components

Senseonics lays out hopes for next-gen CGM commercial timelines

June 24, 2025 By Sean Whooley

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose monitors (CGMs). The maker of the Eversense 365 year-long implantable CGM hosted an analyst event during the American Diabetes … [Read More...] about Senseonics lays out hopes for next-gen CGM commercial timelines

In case you missed it

  • Mannkind looks to give those with diabetes another option through inhaled insulin
  • Omnipod 5 rollout for type 2 advances as Insulet pursues next-gen automation
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy
  • Next-gen Medtronic insulin pump reportedly set for FDA submission, patch pump on the way
  • Analysts expect Beta Bionics patch pump launch by 2027
  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Abbott could pave new roads in diabetes management with dual sensor on the horizon

Clinical Trials

Medtronic Onyx LES (1)

Medtronic enrolls first patient in study for Onyx liquid embolic system

Medtronic [WtwhTicker symbol=”MDT”](NYSE: MDT)[/WtwhTicker] today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES). PELE (Peripheral Onyx Liquid Embolic) evaluates the safety of Onyx LES for the embolization of arterial hemorrhage in the peripheral vasculature. Dr. Christopher Stark performed the first procedure at Albany Medical Center. Onyx LES, […]

GlucoModicum needle-free CGM (1)

GlucoModicum has positive data for needle-free CGM

GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose monitor (CGM). Helsinki, Finland-based GlucoModicum said in a news release that the study helps put the company on “a clear path to commercialization.” The study involved 646 participant visits, including individuals with type 2 diabetes and healthy volunteers. The company […]

Glucotrack 3-year continuous blood glucose monitor (CBGM)

Glucotrack first-in-human study of long-term CBGM implant meets endpoints

Glucotrack (Nasdaq:GCTK) today announced the results from the first-in-human clinical study of its long-term continuous blood glucose monitor (CBGM). Rutherford, New Jersey-based Glucotrack shared findings at the American Diabetes Association’s 85th Scientific Sessions in Chicago. (See all the biggest stories out of ADA 2025 here.) Glucotrack’s device features no on-body external component. The company designed […]

ADA Logo in Chicago American Diabetes Association 85th Scientific Sessions

The biggest diabetes tech stories out of ADA 2025

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association’s 85th Scientific Sessions. At last year’s edition in Orlando, type 2 diabetes dominated the conversation. This time around, type 2 remained a hot topic, alongside new players in the continuous glucose monitor (CGM) and automated insulin delivery market, […]

MannKind afrezza inhaled insulin in use

Mannkind looks to give those with diabetes another option through inhaled insulin

For those living with diabetes, MannKind offers a very different alternative to the current methods of insulin delivery. Founded in 1991 by Alfred E. Mann, a medtech visionary who played a large part in the wider adoption of insulin pumps as the founder of MiniMed, the company develops Afrezza — a fast-acting insulin formulation delivered […]

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS